THC.CN - THC Biomed Intl Ltd.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 526.35M
Enterprise Value 326.89M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)20.72
Price/Book (mrq)1.68
Enterprise Value/Revenue 321.15
Enterprise Value/EBITDA 6-20.70

Trading Information

Stock Price History

Beta (3Y Monthly) 2.57
52-Week Change 3-81.72%
S&P500 52-Week Change 33.22%
52 Week High 31.0100
52 Week Low 30.1400
50-Day Moving Average 30.1732
200-Day Moving Average 30.2567

Share Statistics

Avg Vol (3 month) 3262.76k
Avg Vol (10 day) 3275.99k
Shares Outstanding 5146.38M
Float 106.18M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Aug 15, 2019) 447.03k
Short Ratio (Aug 15, 2019) 40.51
Short % of Float (Aug 15, 2019) 4N/A
Short % of Shares Outstanding (Aug 15, 2019) 40.07%
Shares Short (prior month Jul 15, 2019) 459.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Feb 4, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 31, 2018
Most Recent Quarter (mrq)Apr 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-139.87%

Management Effectiveness

Return on Assets (ttm)-6.57%
Return on Equity (ttm)-81.72%

Income Statement

Revenue (ttm)1.27M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)97.10%
Gross Profit (ttm)457.79k
EBITDA -1.3M
Net Income Avi to Common (ttm)-11.73M
Diluted EPS (ttm)-0.0930
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)298.61k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.57M
Total Debt/Equity (mrq)9.98
Current Ratio (mrq)2.73
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-2.06M
Levered Free Cash Flow (ttm)-9.25M